Dr. Webster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 North Broadway Street
Weinberg BLDG
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017- Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2013
Stanford University School of MedicineClass of 2011
Certifications & Licensure
VA State Medical License 2021 - 2026
MD State Medical License 2014 - 2025
PA State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance Start of enrollment: 2017 Sep 05
Roles: Contact, Principal Investigator
- Post-transplant Flotetuzumab for AML Start of enrollment: 2022 Oct 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 58 citationsAcute myeloid leukemia in the elderly: therapeutic options and choiceJonathan Webster, Keith W. Pratz
Leukemia & Lymphoma. 2018-02-01 - 41 citationsRandomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemiaJonathan Webster, Raoul Tibes, Lawrence E. Morris, Amanda L. Blackford, Mark R. Litzow
Leukemia Research. 2017-10-01 - 5 citationsOutcome heterogeneity of-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation.Sergiu Pasca, Saurav D Haldar, Alexander Ambinder, Jonathan A Webster, Tania Jain
Haematologica. 2024-03-01
Abstracts/Posters
- Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AMLJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume LeukapheresisJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF RegistryJune 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
